Login
$PTCT
$62.09 +$1.02 (1.67%) Close

Ownership

13F as of Q2 2026 · 83.5M shares outstanding

Who owns PTCT?

By type of holder
Institutions 100.0% Insiders 0.0% Everyone else 0.0%
Concentration Top 10 holders own 107.3%
BlackRock, Inc. 29.3% · State Street Corp 11.9%
Institutional ownership
100.0%
0 pts vs last qtr
Institutional holders
444
+16 vs last qtr
Net shares bought
+6.7M
by institutions in Q2 2026
New / sold out
72 / 56
positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026
  • Jupiter Topco LLC NEW +7.3M
  • Westfield Capital Management Co LP NEW +2.0M

Sign up to see all 5.

Biggest sellers in Q2 2026
  • Janus Henderson Group PLC SOLD OUT −7.2M
  • Prosight Management, LP −1.3M

Sign up to see all 5.

Who is planning to sell?

Notices of proposed sale, last 12 months
$57.2M
88 notices from 15 people
Shares covered
747.1K
0.90% of the company
Arranged in advance
87%
of the value is under a 10b5-1 plan
Under a 10b5-1 plan No plan
$0$6.3M$12.5MNov 2025: $12.5M under a 10b5-1 planNovDec 2025: $4.9M under a 10b5-1 planDec 2025: $891.0K without a planDecJan 2026: $2.3M under a 10b5-1 planJan 2026: $2.4M without a planJanFeb 2026: $401.5K under a 10b5-1 planFeb 2026: $1.7M without a planFebMar 2026: $2.3M under a 10b5-1 planMar 2026: $170.6K without a planMarApr 2026: $3.7M under a 10b5-1 planApr 2026: $258.5K without a planAprMay 2026: $483.3K under a 10b5-1 planMay 2026: $917.1K without a planMayJun 2026: $8.8M under a 10b5-1 planJunJul 2026: $6.2M under a 10b5-1 planJul 2026: $280.7K without a planJulAug 2026: $3.9M under a 10b5-1 planAug 2026: $705.8K without a planAugSep 2026: $3.5M under a 10b5-1 planSepOct 2026: $788.6K under a 10b5-1 planOct
Largest proposed sellers
  • Almstead Neil Gregory Officer $22.1M
  • Pauwels Eric Officer $7.48M

Sign up to see all 5.

Every notice on Red Flags →

A Form 144 is notice of a planned sale, not the sale itself. What insiders actually sold is on Insider Transactions.

Is your stake being diluted?

Diluted share count, FY2012–FY2025
+513189.7%
+158.38% a year
Each share's claim on the business
−100.0%
shrank without buying or selling a share
Spent on buybacks vs paid in stock
— vs $607M
over 10 fiscal years
Diluted shares, split-adjusted
16.7K44.6M89.2M2012: 17.2K shares'122013: 12.8M shares'132014: 31.6M shares'142019: 58.9M shares'192020: 66.0M shares'202021: 70.5M shares'212022: 71.7M shares'222023: 74.8M shares'232024: 76.8M shares'242025: 88.3M shares'25
Buybacks Stock-based comp
$0$55.2M$110.3M2012 buybacks: $02012 stock comp: $2.3M'122013 buybacks: $02013 stock comp: $8.4M'132014 buybacks: $02014 stock comp: $19.3M'142019 buybacks: $02019 stock comp: $42.1M'192020 buybacks: $02020 stock comp: $70.3M'202021 buybacks: $02021 stock comp: $103.5M'212022 buybacks: $02022 stock comp: $110.3M'222023 buybacks: $02023 stock comp: $101.6M'232024 buybacks: $02024 stock comp: $74.6M'242025 buybacks: $02025 stock comp: $74.5M'25

How patient are the owners?

Institutional shares by how long they've been held
5+ years65% 3–5 years7% 1–3 years13% Under 1 year15%
Quarterly turnover
15.7%
of institutional shares changed hands
Top 10 managers, median time held
5 years

Super Investors

Investment managers reporting PTCT on Form 13F
B
BlackRock, Inc.
Shares
24.5M
% of company
29.32%
Change vs last qtr
+1.9M (+8.4%)
Held since
≤2021
SS
State Street Corp
Shares
9.9M
% of company
11.90%
Change vs last qtr
+1.1M (+12.1%)
Held since
≤2021

28 more super investors behind a free account

See every manager holding PTC Therapeutics, Inc., how their position has changed, and how long they've held it.

Sign up free

Institutional Funds

Mutual funds and ETFs reporting PTCT on Form N-PORT; together they hold 76.2% of the company
Position value
$408M
% of company
5.99%
% of the fund
0.37%
As of
June 30, 2026
VT
Position value
$246M
% of company
6.51%
% of the fund
0.01%
As of
June 30, 2026

23 more funds behind a free account

See every fund holding PTC Therapeutics, Inc. and how much of the fund the position is.

Sign up free

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G
SM
Schmertzler Michael
Insider
Shares
2.8M
% of company
3.30%
Change vs last qtr
—
Held since
—
GP
Gravier Pierre
Insider
Shares
839.9K
% of company
1.01%
Change vs last qtr
—
Held since
—

16 more holders behind a free account

See every insider and 5%+ holder of PTC Therapeutics, Inc..

Sign up free

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support